Results 161 to 170 of about 126,775 (264)

Equity in Access to Health Services for People in Poor Urban Areas in Alexandria

Journal of High Institute of Public Health, 2003
Hoda Abdul-Kader, Mona Hassan
openaire   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Open-Source Large Language Models and AI Health Equity: A Health Service Triangle Model Perspective. [PDF]

J Med Internet Res
Wu S, Zou W, Tu J, Wang C, Jin C, Liao J, Tang KC, Liu N, Hao C.   +8 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Digital navigation as an access barrier: waiting times, equity, and universal health coverage in a digitalizing health system. [PDF]

Front Public Health
Memmel E, Kerschbaumer L.
europepmc   +1 more source

Precision medicine in paediatrics: Progress and priorities

British Journal of Clinical Pharmacology, EarlyView.
Precision medicine is revolutionizing personalized healthcare, advancing both diagnostics and therapeutics at an unprecedented pace. Reviewing the paediatric applications of pharmacometrics, pharmacogenomics and advanced therapy medicinal products highlights not only the relevance of these exciting innovations to frontline care but also the significant
Nicola Husain, Claire Booth, Joseph F. Standing, Charlotte I. S. Barker   +3 more
wiley   +1 more source

Transforming psychological health services toward equity and global access

Discover Public Health
Abdullahi Hassan Elmi, Fahma Hussein Ibrahim, Abdishakor Mohamud Ahmed, Ahmed Omar Abdi   +3 more
openaire   +1 more source

Pregnancy‐related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis

British Journal of Clinical Pharmacology, EarlyView.
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas, Naim Bouazza, Frantz Foissac, Saïk Urien, Léo Froelicher‐Bournaud, Gabrielle Lui, Victoria Guillemart, Nicolas Carlier, Jennifer Da Silva, Johanna Fesenbeckh, Reem Kanaan, Isabelle Honoré, Clémence Martin, Jean‐Marc Treluyer, Vassilis Tsatsaris, Pierre‐Régis Burgel, Sihem Benaboud   +16 more
wiley   +1 more source

Digital clinic users in Finnish public primary care: their characteristics, reasons for visits, and equity considerations - a register study. [PDF]

Scand J Prim Health Care
Kujansivu K, Tolvanen E, Haaga T, Sääksvuori L, Kortelainen M, Nokso-Koivisto O, Koskela TH.   +6 more
europepmc   +1 more source

Craniofacial Health Care in Southeast Asia: The Unfinished Agenda of Universal Health Coverage. [PDF]

Int Dent J
Nalabothu P, Marya A, Allareddy V.
europepmc   +1 more source